{"entity":{"id":"richard-van-etten","kind":"person","name":"Richard Van Etten","aka":[],"tldr":"Physician-scientist who directs the Chao Family Comprehensive Cancer Center at UC Irvine, the NCI-designated comprehensive cancer centre for Orange County.","summary":"Richard Van Etten, MD, PhD, is Director of the Chao Family Comprehensive Cancer Center at the University of California, Irvine, and also serves as Senior Associate Dean and Associate Vice Chancellor for Cancer. The centre's leadership page lists Miguel Villalona Calero, MD, Division Chief of Hematology/Oncology, as Deputy Director, with associate directors covering basic science, clinical sciences, translational science, population science, community outreach, shared resources, education and administration. Executive decision-making is vested in a Senior Leadership Council chaired by the Director.","asOf":"2026-09-10","links":[{"label":"Source: Chao Family Comprehensive Cancer Center leadership page","url":"https://cancer.uci.edu/about/leadership/"}],"tags":["leadership","clinician-scientist","comprehensive-cancer-centre"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["uci-chao"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["haematologica","elife"],"dependsOn":[],"notes":[],"role":"Director, Chao Family Comprehensive Cancer Center, University of California, Irvine","institutionId":"uci-chao","specialisms":["Haematological malignancies","Leukaemia biology","Cancer centre leadership"],"profiles":[{"label":"Chao Family Comprehensive Cancer Center leadership page","url":"https://cancer.uci.edu/about/leadership/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Van+Etten+RA%5BAuthor%5D"}],"papers":[{"title":"Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia","journal":"Haematologica","year":2016,"doi":"10.3324/haematol.2016.152710"},{"title":"Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond","journal":"Hematology","year":2013,"doi":"10.1182/asheducation-2013.1.189"},{"title":"Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy","journal":"eLife","year":2023,"doi":"10.7554/elife.84149"}],"orcid":"0000-0003-0000-635X"},"route":"/people/richard-van-etten/","neighbours":{"institution":[{"id":"uci-chao","kind":"institution","name":"Chao Family Comprehensive Cancer Center, UC Irvine","route":"/institutions/uci-chao/"}],"journal":[{"id":"elife","kind":"journal","name":"eLife","route":"/journals/elife/"},{"id":"haematologica","kind":"journal","name":"Haematologica","route":"/journals/haematologica/"}]}}